实践与医师水平差异在低危前列腺癌男性主动监测中的应用：对协作质量改进的影响。
Practice- vs Physician-Level Variation in Use of Active Surveillance for Men With Low-Risk Prostate Cancer: Implications for Collaborative Quality Improvement.
机构信息
Department of Urology, University of Michigan, Ann Arbor.
Division of Urology, Spectrum Health, Grand Rapids, Michigan.
出版信息
JAMA Surg. 2017 Oct 1;152(10):978-980. doi: 10.1001/jamasurg.2017.1586.
Abstract
This study examines the proportion of men treated primarily with active surveillance across practices and among urologists in the Michigan Urological Surgery Improvement Collaborative.
摘要
本研究考察了密歇根州泌尿外科学术改进协作组织中各实践和泌尿科医生中主要采用主动监测治疗的男性比例。
相似文献
1
Practice- vs Physician-Level Variation in Use of Active Surveillance for Men With Low-Risk Prostate Cancer: Implications for Collaborative Quality Improvement.实践与医师水平差异在低危前列腺癌男性主动监测中的应用：对协作质量改进的影响。
JAMA Surg. 2017 Oct 1;152(10):978-980. doi: 10.1001/jamasurg.2017.1586.
2
Contemporary use of initial active surveillance among men in Michigan with low-risk prostate cancer.密歇根州低危前列腺癌男性中初始主动监测的当代应用。
Eur Urol. 2015 Jan;67(1):44-50. doi: 10.1016/j.eururo.2014.08.024. Epub 2014 Aug 24.
3
Urologist-Level Correlation in the Use of Observation for Low- and High-Risk Prostate Cancer.泌尿科医生在低危和高危前列腺癌观察中的应用的相关性。
JAMA Surg. 2017 Jan 1;152(1):27-34. doi: 10.1001/jamasurg.2016.2907.
4
Re: Contemporary use of initial active surveillance among men in Michigan with low-risk prostate cancer.回复：密歇根州低风险前列腺癌男性患者初始主动监测的当代应用情况
J Urol. 2015 Jan;193(1):128-9. doi: 10.1016/j.juro.2014.10.076. Epub 2014 Oct 22.
5
Variation in Guideline Concordant Active Surveillance Followup in Diverse Urology Practices.不同泌尿外科实践中指南一致的主动监测随访的差异。
J Urol. 2017 Mar;197(3 Pt 1):621-626. doi: 10.1016/j.juro.2016.09.071. Epub 2016 Sep 20.
6
Use of Prostate-Specific Antigen Testing Is in the Eye of the Beholder.前列腺特异性抗原检测的应用因人而异。
JAMA Intern Med. 2016 Apr;176(4):547-8. doi: 10.1001/jamainternmed.2015.8104.
7
Urologists reduce overtreatment in prostate cancer.泌尿科医生减少了前列腺癌的过度治疗。
Lancet Oncol. 2018 Aug;19(8):e384. doi: 10.1016/S1470-2045(18)30478-9. Epub 2018 Jun 21.
8
Implementing Continuous Quality Improvement in an Integrated Community Urology Practice: Lessons Learned.在综合性社区泌尿科实践中实施持续质量改进：经验教训。
Urology. 2021 Jul;153:139-146. doi: 10.1016/j.urology.2020.11.068. Epub 2021 Jan 19.
9
Variation in prostate cancer care.前列腺癌治疗的差异。
JAMA. 2015 May 26;313(20):2066-7. doi: 10.1001/jama.2015.0607.
10
Physician social networks and variation in prostate cancer treatment in three cities.医生社交网络与三个城市前列腺癌治疗的差异
Health Serv Res. 2012 Feb;47(1 Pt 2):380-403. doi: 10.1111/j.1475-6773.2011.01331.x. Epub 2011 Oct 18.
引用本文的文献
1
Estimating optimally tailored active surveillance strategy under interval censoring.在区间删失情况下估计最优定制的主动监测策略。
Biometrics. 2025 Apr 2;81(2). doi: 10.1093/biomtc/ujaf067.
2
Trends in Surgical Overtreatment of Prostate Cancer.前列腺癌手术过度治疗的趋势
JAMA Oncol. 2025 Apr 28. doi: 10.1001/jamaoncol.2025.0963.
3
Use and Usefulness of Risk Prediction Tools in Urologic Surgery: Current State and Path Forward.风险预测工具在泌尿外科手术中的应用及效用：现状与未来方向
Urol Pract. 2025 Jul;12(4):459-468. doi: 10.1097/UPJ.0000000000000808. Epub 2025 Mar 11.
4
Organizational characteristics associated with sustained participation in internal quality improvement: Findings from two waves of a national sample of physician practices in the United States.与持续参与内部质量改进相关的组织特征：来自美国全国医生执业样本两波调查的结果
Soc Sci Med. 2025 Mar;369:117826. doi: 10.1016/j.socscimed.2025.117826. Epub 2025 Feb 8.
5
Physician Payment Incentives and Active Surveillance in Low-Risk Prostate Cancer.低风险前列腺癌的医生薪酬激励与主动监测
JAMA Netw Open. 2025 Jan 2;8(1):e2453658. doi: 10.1001/jamanetworkopen.2024.53658.
6
Patient and physician perspectives on treatments for low-risk prostate cancer: a qualitative study.患者和医生对低危前列腺癌治疗方法的看法：一项定性研究。
BMC Cancer. 2023 Dec 5;23(1):1191. doi: 10.1186/s12885-023-11679-4.
7
Location and Types of Treatment for Prostate Cancer After the Veterans Choice Program Implementation.退伍军人选择计划实施后前列腺癌的治疗地点和类型。
JAMA Netw Open. 2023 Oct 2;6(10):e2338326. doi: 10.1001/jamanetworkopen.2023.38326.
8
Impact of genomic testing on urologists' treatment preference in favorable risk prostate cancer: A randomized trial.基因组检测对低危前列腺癌中泌尿科医生治疗偏好的影响：一项随机试验。
Cancer Med. 2023 Oct;12(19):19690-19700. doi: 10.1002/cam4.6615. Epub 2023 Oct 3.
9
Use of expectant management based on prostate cancer risk and health status: How far are we from a risk-adapted approach?基于前列腺癌风险和健康状况的期待治疗管理：我们距离风险适应方法还有多远？
Urol Oncol. 2023 Jul;41(7):323.e17-323.e25. doi: 10.1016/j.urolonc.2023.04.006. Epub 2023 May 5.
10
Time Trends and Variation in the Use of Active Surveillance for Management of Low-risk Prostate Cancer in the US.美国低危前列腺癌管理中主动监测应用的时间趋势和变化。
JAMA Netw Open. 2023 Mar 1;6(3):e231439. doi: 10.1001/jamanetworkopen.2023.1439.
本文引用的文献
1
Uptake of Active Surveillance for Very-Low-Risk Prostate Cancer in Sweden.瑞典极低危前列腺癌主动监测的应用。
JAMA Oncol. 2017 Oct 1;3(10):1393-1398. doi: 10.1001/jamaoncol.2016.3600.
2
Appropriateness Criteria for Active Surveillance of Prostate Cancer.前列腺癌主动监测的适宜性标准。
J Urol. 2017 Jan;197(1):67-74. doi: 10.1016/j.juro.2016.07.005. Epub 2016 Jul 14.
3
Prostate Cancer, Version 1.2016.前列腺癌临床实践指南（2016 年版）
J Natl Compr Canc Netw. 2016 Jan;14(1):19-30. doi: 10.6004/jnccn.2016.0004.
4
Trends in Management for Patients With Localized Prostate Cancer, 1990-2013.1990 - 2013年局限性前列腺癌患者的管理趋势
JAMA. 2015 Jul 7;314(1):80-2. doi: 10.1001/jama.2015.6036.
5
Contemporary use of initial active surveillance among men in Michigan with low-risk prostate cancer.密歇根州低危前列腺癌男性中初始主动监测的当代应用。
Eur Urol. 2015 Jan;67(1):44-50. doi: 10.1016/j.eururo.2014.08.024. Epub 2014 Aug 24.
6
Physician variation in management of low-risk prostate cancer: a population-based cohort study.低危前列腺癌管理中的医生变异性：基于人群的队列研究。
JAMA Intern Med. 2014 Sep;174(9):1450-9. doi: 10.1001/jamainternmed.2014.3021.
Zotero 插件